Cargando…
The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study
SIMPLE SUMMARY: Patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) are at risk of significant treatment burden. Multiple studies have reported on patient-reported outcome (PRO) measurements of these patients. However, outcomes are difficult to inter...
Autores principales: | Bakkers, Checca, van de Vlasakker, Vincent C. J., Rovers, Koen P. B., Lurvink, Robin J., Nienhuijs, Simon W., Burger, Jacobus W. A., Creemers, Geert-Jan M., Bonhof, Cynthia S., Mols, Floortje, de Hingh, Ignace H. J. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913313/ https://www.ncbi.nlm.nih.gov/pubmed/36765746 http://dx.doi.org/10.3390/cancers15030788 |
Ejemplares similares
-
ASO Author Reflections: Patient-Reported Outcomes of the CAIRO6 Phase II Trial
por: Bakkers, Checca, et al.
Publicado: (2023) -
Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023) -
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017) -
The use of Hypotension Prediction Index in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Gangakhedkar, Gauri R., et al.
Publicado: (2022) -
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016)